1. |
Sarcinella L, Mazzulli T, Willey B, et al. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients [J]. J Clin Virol, 2002; 24(1-2)∶99.
|
2. |
Turgeon N, Fishman JA, Doran M, et al. Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir [J]. Transpl Infect Dis, 2000; 2(1)∶2.
|
3. |
Falagas ME, Snydman DR, Ruthazer R, et al. Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group [J]. Clin Infect Dis, 1996; 23(2)∶292.
|
4. |
Portela D, Patel R, LarsonKeller JJ, et al. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation [J]. J Infect Dis, 1995; 171(4)∶1014.
|
5. |
Mutimer DJ, Shaw J, O’Donnell K, et al. Enhanced (cytomegalovirus) viral replication after transplantation for fulminant hepatic failure [J]. Liver Transpl Surg, 1997; 3(5)∶506.
|
6. |
Paterson DL, Staplefeldt WH, Wagener MM, et al. Intraoperative hypothermia is an independent risk factor for early cytomegalovirus infection in liver transplant recipients [J]. Transplantation, 1999; 67(8)∶1151.
|
7. |
Everson GT, Kam I. Liver transplantation: current status and unresolved controversies [J]. Adv Intern Med, 1997; 42∶505.
|
8. |
Satou J, Funato T, Satoh N, et al. Quantitative PCR determination of human cytomegalovirus in blood cells [J]. J Clin Lab Anal, 2001; 15(3)∶122.
|
9. |
Piiparinen H, Hockerstedt K, Lappalainen M, et al. Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients [J]. J Clin Microbiol, 2002; 40(8)∶2945.
|
10. |
Mendez JC, Espy MJ, Smith TF, et al. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation [J]. J Clin Microbiol, 1998; 36(2)∶526.
|
11. |
Niubo J, Perez JL, MartinezLacasa JT, et al. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients [J]. Diagn Microbiol Infect Dis, 1996; 24(1)∶19.
|
12. |
Kusne S, Grossi P, Irish W, et al. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients [J]. Transplantation, 1999; 68(8)∶1125.
|
13. |
Singhal S, Shaw JC, Ainsworth J, et al. Direct visualization and quantitation of cytomegalovirusspecific CD8+ cytotoxic Tlymphocytes in liver transplant patients [J]. Transplantation, 2000; 69(11)∶2251.
|
14. |
Benz C, Utermohlen O, Wulf A, et al. Activated virusspecific T cells are early indicators of antiCMV immune reactions in liver transplant patients [J]. Gastroenterology, 2002; 122(5)∶1201.
|
15. |
Dockrell DH, Prada J, Jones MF, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease [J]. J Infect Dis, 1997; 176(5)∶1135.
|
16. |
Lautenschlager I, Hockerstedt K, Jalanko H, et al. Persistent cytomegalovirus in liver allografts with chronic rejection [J]. Hepatology, 1997; 25(1)∶190.
|
17. |
van den Berg AP, Klompmaker IJ, Haagsma EB, et al. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection [J]. Clin Transplant, 1996; 10(2)∶224.
|
18. |
Gavalda J, de Otero J, Murio E, et al. Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMVseropositive liver transplant recipients [J]. Transpl Int, 1997; 10(6)∶462.
|
19. |
Winston DJ, Wirin D, Shaked A, et al. Randomised comparison of ganciclovir and highdose acyclovir for longterm cytomegalovirus prophylaxis in livertransplant recipients [J]. Lancet, 1995; 346(8967)∶69.
|
20. |
Badley AD, Seaberg EC, Porayko MK, et al. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database [J]. Transplantation, 1997; 64(1)∶66.
|
21. |
Kanj SS, Sharara AI, Clavien PA, et al. Cytomegalovirus infection following liver transplantation: review of the literature [J]. Clin Infect Dis,,1996; 22(3)∶537.
|
22. |
Tarp BD, Astrup LB. Should recurrent cytomegalovirus infections in patients with liver transplantation be treated? [J]. Ugeskr Laeger, 1997; 159(22)∶3413.
|